BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35222362)

  • 1. FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer.
    Sarkar T; Dhar S; Chakraborty D; Pati S; Bose S; Panda AK; Basak U; Chakraborty S; Mukherjee S; Guin A; Jana K; Sarkar DK; Sa G
    Front Immunol; 2022; 13():740588. PubMed ID: 35222362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foxp3
    Maeda S; Nakazawa M; Uchida M; Yoshitake R; Nakagawa T; Nishimura R; Miyamoto R; Bonkobara M; Yonezawa T; Momoi Y
    Vet Pathol; 2020 Jul; 57(4):497-506. PubMed ID: 32347186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
    Sugiyama D; Nishikawa H; Maeda Y; Nishioka M; Tanemura A; Katayama I; Ezoe S; Kanakura Y; Sato E; Fukumori Y; Karbach J; Jäger E; Sakaguchi S
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17945-50. PubMed ID: 24127572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
    Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
    J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer.
    Maeda S; Motegi T; Iio A; Kaji K; Goto-Koshino Y; Eto S; Ikeda N; Nakagawa T; Nishimura R; Yonezawa T; Momoi Y
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35131860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.
    Gobert M; Treilleux I; Bendriss-Vermare N; Bachelot T; Goddard-Leon S; Arfi V; Biota C; Doffin AC; Durand I; Olive D; Perez S; Pasqual N; Faure C; Ray-Coquard I; Puisieux A; Caux C; Blay JY; Ménétrier-Caux C
    Cancer Res; 2009 Mar; 69(5):2000-9. PubMed ID: 19244125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer.
    Maeda S; Murakami K; Inoue A; Yonezawa T; Matsuki N
    Cancer Immunol Res; 2019 Jul; 7(7):1175-1187. PubMed ID: 31160277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8
    Chakraborty S; Panda AK; Bose S; Roy D; Kajal K; Guha D; Sa G
    Sci Rep; 2017 May; 7(1):1628. PubMed ID: 28487507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
    Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
    J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumors establish resistance to immunotherapy by regulating T
    Marshall LA; Marubayashi S; Jorapur A; Jacobson S; Zibinsky M; Robles O; Hu DX; Jackson JJ; Pookot D; Sanchez J; Brovarney M; Wadsworth A; Chian D; Wustrow D; Kassner PD; Cutler G; Wong B; Brockstedt DG; Talay O
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33243932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener's granulomatosis.
    Klapa S; Mueller A; Csernok E; Fagin U; Klenerman P; Holl-Ulrich K; Gross WL; Lamprecht P
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):72-80. PubMed ID: 20412707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling of the tumor microenvironment via disrupting Blimp1
    Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
    Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.
    Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW
    Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
    Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
    J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
    Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
    Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 alters migration capacity of CD4
    He S; Xue M; Cai G
    Scand J Immunol; 2021 Nov; 94(5):e13099. PubMed ID: 34940981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXP3+ Cells Recruited by CCL22 into Breast Cancer Correlates with Less Tumor Nodal Infiltration.
    Freier CP; Kuhn C; Endres S; Mayr D; Friese K; Jeschke U; Anz D
    Anticancer Res; 2016 Jun; 36(6):3139-45. PubMed ID: 27272839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
    Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
    Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.
    Olkhanud PB; Baatar D; Bodogai M; Hakim F; Gress R; Anderson RL; Deng J; Xu M; Briest S; Biragyn A
    Cancer Res; 2009 Jul; 69(14):5996-6004. PubMed ID: 19567680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J; Hedenfalk I; Hagerling C
    Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.